Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000375 | Streptomycin | 0.76 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 8'-Hydroxydihydroergotamine | 0.76 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Cys Phe Arg | 0.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 6'''-Deamino-6'''-dehydro-6'''-oxoneomycin C | 0.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Calystegin B2 | 0.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Paratocarpin F | 0.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 3-O-acetylecdysone 2-phosphate | 0.85 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Kanokoside D | 0.86 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 5-Hydroxyisourate | 0.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 5-Methylcytidine | 0.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Methacrifos | 0.91 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 5,7,8-Trihydroxy-3-methoxyflavone 8-((E)-2-methylbut-2-enoate) | 0.92 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 4-Methylene-L-glutamine | 0.93 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2-Amino-3-methyl-1-butanol | 0.94 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Actinidine | 0.94 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 5-Aminopentanoic acid | 0.95 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 3-Guanidinopropanoate | 0.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Creatinine | 1.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Cytarabine | 1.32 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2-Hydroxyadenine | 1.32 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | allopurinol | 1.33 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 4-Chloromethandienone | 1.38 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Dalfopristin | 1.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Enilconazole | 1.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Diethylene glycol | 1.62 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 6-Methoxyquinoline | 3.58 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2-Hydroxyiminodibenzyl glucuronide | 3.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | (-)-Hygroline | 4.13 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | D-Proline | 4.43 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Penicillin G | 4.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Quercetin 3-(6''-malonylglucoside)-7-glucoside | 4.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Met-Trp-OH | 4.72 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | FKGK 11 | 4.94 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2(N)-Methyl-norsalsolinol | 5.02 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Saxitoxin | 5.02 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | ?Ethanolamine | 5.02 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Bispyribac | 5.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | acetohydroxamic acid | 5.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Phenylacetylglycine | 5.09 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Taurohyocholic acid | 5.23 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PE(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)) | 5.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Citiolone | 5.31 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Asn Phe Met | 5.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Tyrphostin B44 (-) | 5.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Auriculine | 5.39 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 6-Hydroxytricetin 6,7,3',5'-tetramethyl eter 5-robinobioside | 5.4 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Ascorbyl Palmitate | 5.5 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PS(22:0/0:0) | 5.53 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Malyngamide J | 5.57 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | N-(4-benzenesulfonamide) arachidonoyl amine | 5.59 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | LysoPE(16:1(9Z)/0:0) | 5.6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Cimicifugoside | 5.62 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Cabergoline | 5.69 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Digitoxigenin bisdigitoxoside | 5.69 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PE(9:0/9:0)[U] | 5.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Mycinamicin IV | 5.8 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PE(19:0/0:0) | 5.84 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Erythromycin B | 5.9 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Westiellamide | 5.91 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Diacetoxyscirpenol | 5.93 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Elloramycin A | 5.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 3'-Amino-3'-deoxy-AMP | 5.97 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Solamargine | 6.01 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Mycobactin S | 6.08 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Pyrrhoxanthin | 6.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 4-Oxomytiloxanthin | 6.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Delcosine | 6.28 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Nevadensin 5-gentiobioside | 6.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PG(18:0/0:0) | 6.47 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PE(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) | 6.51 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Isoalangiside | 6.78 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Daunorubicin | 7.11 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Ala Trp Trp | 7.6 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Cyclopiazonic Acid | 7.96 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 5-O-Methylvisamminol | 8.77 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 3-oxo-dodecanoic acid | 8.87 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | (-)-11-hydroxy-9,10-dihydrojasmonic acid | 8.99 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Burseran | 9.36 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | Dodecanedioic acid | 10.58 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 8,9,16-trihydroxy palmitic acid | 11.15 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2-tetracosanamidoethanesulfonic acid | 11.16 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | AM1172 | 11.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | 2-hexacosanamidoethanesulfonic acid | 12.14 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | (±)N-(1-methyl-2-hydroxy-2-phenyl-ethyl) arachidonyl amine | 12.17 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages | |
| AN000375 | PS(O-16:0/22:0) | 13.41 | Minutes | ST000242 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Macrophages |
